These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20045404)

  • 1. Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6.
    Shimamura K; Nagumo A; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
    Eur J Pharmacol; 2010 Mar; 630(1-3):34-41. PubMed ID: 20045404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
    Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
    J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a selective radioligand for ELOVL6.
    Shimamura K; Takahashi H; Kitazawa H; Miyamoto Y; Nagumo A; Tang C; Dean D; Nagase T; Sato N; Tokita S
    J Biochem; 2009 Sep; 146(3):429-37. PubMed ID: 19505953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors.
    Mizutani T; Ishikawa S; Nagase T; Takahashi H; Fujimura T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 Nov; 52(22):7289-300. PubMed ID: 19883081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a novel indoledione class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.
    Takahashi T; Nagase T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 May; 52(10):3142-5. PubMed ID: 19388647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.
    Nagase T; Takahashi T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 Jul; 52(14):4111-4. PubMed ID: 19522500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.
    Sasaki T; Nagase T; Takahashi T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    Bioorg Med Chem; 2009 Aug; 17(15):5639-47. PubMed ID: 19596583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
    Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N
    Nat Med; 2007 Oct; 13(10):1193-202. PubMed ID: 17906635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Saito R; Matsuzaka T; Karasawa T; Sekiya M; Okada N; Igarashi M; Matsumori R; Ishii K; Nakagawa Y; Iwasaki H; Kobayashi K; Yatoh S; Takahashi A; Sone H; Suzuki H; Yahagi N; Yamada N; Shimano H
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1973-9. PubMed ID: 21817094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout.
    Shimano H
    Prog Lipid Res; 2012 Jul; 51(3):267-71. PubMed ID: 22266797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
    Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
    J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elovl6 promotes nonalcoholic steatohepatitis.
    Matsuzaka T; Atsumi A; Matsumori R; Nie T; Shinozaki H; Suzuki-Kemuriyama N; Kuba M; Nakagawa Y; Ishii K; Shimada M; Kobayashi K; Yatoh S; Takahashi A; Takekoshi K; Sone H; Yahagi N; Suzuki H; Murata S; Nakamuta M; Yamada N; Shimano H
    Hepatology; 2012 Dec; 56(6):2199-208. PubMed ID: 22753171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
    Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
    J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice.
    Sunaga H; Matsui H; Ueno M; Maeno T; Iso T; Syamsunarno MR; Anjo S; Matsuzaka T; Shimano H; Yokoyama T; Kurabayashi M
    Nat Commun; 2013; 4():2563. PubMed ID: 24113622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
    Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
    Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
    Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
    Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.